236 related articles for article (PubMed ID: 10490773)
1. Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse.
Natsume A; Mizuno M; Ryuke Y; Yoshida J
Gene Ther; 1999 Sep; 6(9):1626-33. PubMed ID: 10490773
[TBL] [Abstract][Full Text] [Related]
2. Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cells.
Nakahara N; Pollack IF; Storkus WJ; Wakabayashi T; Yoshida J; Okada H
Cancer Gene Ther; 2003 Jul; 10(7):549-58. PubMed ID: 12833135
[TBL] [Abstract][Full Text] [Related]
3. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
Tsugawa T; Kuwashima N; Sato H; Fellows-Mayle WK; Dusak JE; Okada K; Papworth GD; Watkins SC; Gambotto A; Yoshida J; Pollack IF; Okada H
Gene Ther; 2004 Nov; 11(21):1551-8. PubMed ID: 15343358
[TBL] [Abstract][Full Text] [Related]
4. Interferon-beta endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: cytocidal effect on glioma transplanted into nude mouse brain.
Yagi K; Hayashi Y; Ishida N; Ohbayashi M; Ohishi N; Mizuno M; Yoshida J
Biochem Mol Biol Int; 1994 Jan; 32(1):167-71. PubMed ID: 8012282
[TBL] [Abstract][Full Text] [Related]
5. A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy.
Wakabayashi T; Natsume A; Hashizume Y; Fujii M; Mizuno M; Yoshida J
J Gene Med; 2008 Apr; 10(4):329-39. PubMed ID: 18220319
[TBL] [Abstract][Full Text] [Related]
6. Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice.
Nomura T; Yasuda K; Yamada T; Okamoto S; Mahato RI; Watanabe Y; Takakura Y; Hashida M
Gene Ther; 1999 Jan; 6(1):121-9. PubMed ID: 10341884
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
[TBL] [Abstract][Full Text] [Related]
8. IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma.
Natsume A; Tsujimura K; Mizuno M; Takahashi T; Yoshida J
J Neurooncol; 2000 Apr; 47(2):117-24. PubMed ID: 10982152
[TBL] [Abstract][Full Text] [Related]
9. Experimental gene therapy against subcutaneously implanted glioma with a herpes simplex virus-defective vector expressing interferon-gamma.
Kanno H; Hattori S; Sato H; Murata H; Huang FH; Hayashi A; Suzuki N; Yamamoto I; Kawamoto S; Minami M; Miyatake S; Shuin T; Kaplitt MG
Cancer Gene Ther; 1999; 6(2):147-54. PubMed ID: 10195881
[TBL] [Abstract][Full Text] [Related]
10. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
Mizuno M; Ryuke Y; Yoshida J
Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
[TBL] [Abstract][Full Text] [Related]
11. Significant antitumoral activity of cationic multilamellar liposomes containing human IFN-beta gene against human renal cell carcinoma.
Nakanishi H; Mizutani Y; Kawauchi A; Ukimura O; Shiraishi T; Hatano M; Mizuno M; Yoshida J; Miki T
Clin Cancer Res; 2003 Mar; 9(3):1129-35. PubMed ID: 12631618
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
Lee J; Wang A; Hu Q; Lu S; Dong Z
Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
[TBL] [Abstract][Full Text] [Related]
13. [Effects of interferons on syngeneic murine malignant glioma-specific killer T cell].
Yamasaki T; Yamashita J; Handa H; Namda Y; Hanaoka M
No Shinkei Geka; 1983 Oct; 11(10):1059-67. PubMed ID: 6196674
[TBL] [Abstract][Full Text] [Related]
14. [Gene therapy using cationic multilamellar liposomes containing human interferon-beta gene against renal cell carcinoma].
Mizutani Y; Nakanishi H; Miki T; Mizuno M; Yoshida J
Hinyokika Kiyo; 2005 Feb; 51(2):71-3. PubMed ID: 15773356
[TBL] [Abstract][Full Text] [Related]
15. Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells.
Plautz GE; Touhalisky JE; Shu S
Cell Immunol; 1997 Jun; 178(2):101-7. PubMed ID: 9225000
[TBL] [Abstract][Full Text] [Related]
16. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
Merritt RE; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
[TBL] [Abstract][Full Text] [Related]
17. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity.
Odaka M; Sterman DH; Wiewrodt R; Zhang Y; Kiefer M; Amin KM; Gao GP; Wilson JM; Barsoum J; Kaiser LR; Albelda SM
Cancer Res; 2001 Aug; 61(16):6201-12. PubMed ID: 11507073
[TBL] [Abstract][Full Text] [Related]
18. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
Loskog A; Tötterman TH; Böhle A; Brandau S
Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
[TBL] [Abstract][Full Text] [Related]
19. Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer.
Ehtesham M; Samoto K; Kabos P; Acosta FL; Gutierrez MA; Black KL; Yu JS
Cancer Gene Ther; 2002 Nov; 9(11):925-34. PubMed ID: 12386831
[TBL] [Abstract][Full Text] [Related]
20. Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma.
Ito S; Natsume A; Shimato S; Ohno M; Kato T; Chansakul P; Wakabayashi T; Kim SU
Cancer Gene Ther; 2010 May; 17(5):299-306. PubMed ID: 19893595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
